Myriad Genetics posted a GAAP loss of $15.2 million for the 3 months of fiscal 2021, down 26.2% from $20.6 million the previous year. Revenue decreased by 22.1% to $145.2 million compared to $186.3 million in the previous year.
Myriad Genetics posted a GAAP loss of $15.2 million for the 3 months of fiscal 2021, down 26.2% from $20.6 million the previous year. Revenue decreased by 22.1% to $145.2 million compared to $186.3 million in the previous year. 
myriad.com
English (US) 